Table 2.
Multivariate analyses of predictors of poor functional outcomes
| OR | 95% CI | P | |
|---|---|---|---|
| Age (increase per unit) | 1.06 | 1.01–1.12 | 0.012 |
| Atrial fibrillation (yes vs. no) | 1.39 | 0.97–1.76 | 0.13 |
| Stroke severity, NIHSS (increase per unit) | 1.08 | 1.03–1.14 | < 0.001 |
| Lesion volumes (increase per unit) | 1.02 | 1.00–1.04 | 0.021 |
| IV thrombolysis and/or mechanical thrombectomy (yes vs. no) | 0.64 | 0.51–0.87 | 0.025 |
| Stroke syndrome (TACS vs other) | 1.62 | 0.65–3.87 | 0.49 |
| Glucose (increase per unit) | 1.19 | 1.05–1.30 | 0.015 |
| CRP (increase per unit) | 1.45 | 1.11–1.76 | 0.003 |
| Adiponectin (increase per unit) | 1.24 | 1.13–1.37 | < 0.001 |
Poor functional outcome was defined as an mRS > 2
OR odd ratio, CI confidence interval, mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, CRP C-reactive protein, TACS total anterior circulation syndrome
Adjusted for significant factors which confirmed in Table 1, including age, atrial fibrillation, IV thrombolysis and/or mechanical thrombectomy, NIHSS at admission, lesion volumes, stroke syndrome, serum levels of glucose, CRP and adiponectin